Inhaled prostacyclin and high-frequency oscillatory ventilation in a premature infant with respiratory syncytial virus-associated respiratory failure

Manoj Gupta, Stephen Guertin, Steve Martin, Said Omar

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In a 29-day-old premature infant with respiratory syncytial virus (RSV) pneumonia, we have shown an additive effect of high-frequency oscillatory ventilation (HFOV) and continuous inhalation of prostacyclin (iPGI2) with improvement of ventilation and oxygenation. The addition of continuous inhaled iPGI2 to HFOV was beneficial in the treatment of hypoxemic respiratory failure owing to RSV-associated pneumonia. The improvement in alveolar recruitment by increasing lung expansion by HFOV along with less ventilation-perfusion mismatch by iPGI2 appears to be responsible for the synergistic effect and favorable clinical outcome. We conclude that the combined therapy of HFOV and continuous inhaled iPGI2 may be considered in RSV-associated hypoxemic respiratory failure in pediatric patients.

Original languageEnglish (US)
Pages (from-to)e442-e445
JournalPediatrics
Volume130
Issue number2
DOIs
StatePublished - Aug 1 2012
Externally publishedYes

Fingerprint

High-Frequency Ventilation
Respiratory Syncytial Viruses
Epoprostenol
Premature Infants
Respiratory Insufficiency
Ventilation
Pneumonia
Inhalation
Perfusion
Pediatrics
Lung
Therapeutics

Keywords

  • Premature infant
  • Prostacyclin inhalation
  • Respiratory failure
  • Respiratory syncytial virus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Inhaled prostacyclin and high-frequency oscillatory ventilation in a premature infant with respiratory syncytial virus-associated respiratory failure. / Gupta, Manoj; Guertin, Stephen; Martin, Steve; Omar, Said.

In: Pediatrics, Vol. 130, No. 2, 01.08.2012, p. e442-e445.

Research output: Contribution to journalArticle

@article{cfbdc9dda23d43aa800f66dd84b039b3,
title = "Inhaled prostacyclin and high-frequency oscillatory ventilation in a premature infant with respiratory syncytial virus-associated respiratory failure",
abstract = "In a 29-day-old premature infant with respiratory syncytial virus (RSV) pneumonia, we have shown an additive effect of high-frequency oscillatory ventilation (HFOV) and continuous inhalation of prostacyclin (iPGI2) with improvement of ventilation and oxygenation. The addition of continuous inhaled iPGI2 to HFOV was beneficial in the treatment of hypoxemic respiratory failure owing to RSV-associated pneumonia. The improvement in alveolar recruitment by increasing lung expansion by HFOV along with less ventilation-perfusion mismatch by iPGI2 appears to be responsible for the synergistic effect and favorable clinical outcome. We conclude that the combined therapy of HFOV and continuous inhaled iPGI2 may be considered in RSV-associated hypoxemic respiratory failure in pediatric patients.",
keywords = "Premature infant, Prostacyclin inhalation, Respiratory failure, Respiratory syncytial virus",
author = "Manoj Gupta and Stephen Guertin and Steve Martin and Said Omar",
year = "2012",
month = "8",
day = "1",
doi = "10.1542/peds.2011-0239",
language = "English (US)",
volume = "130",
pages = "e442--e445",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Inhaled prostacyclin and high-frequency oscillatory ventilation in a premature infant with respiratory syncytial virus-associated respiratory failure

AU - Gupta, Manoj

AU - Guertin, Stephen

AU - Martin, Steve

AU - Omar, Said

PY - 2012/8/1

Y1 - 2012/8/1

N2 - In a 29-day-old premature infant with respiratory syncytial virus (RSV) pneumonia, we have shown an additive effect of high-frequency oscillatory ventilation (HFOV) and continuous inhalation of prostacyclin (iPGI2) with improvement of ventilation and oxygenation. The addition of continuous inhaled iPGI2 to HFOV was beneficial in the treatment of hypoxemic respiratory failure owing to RSV-associated pneumonia. The improvement in alveolar recruitment by increasing lung expansion by HFOV along with less ventilation-perfusion mismatch by iPGI2 appears to be responsible for the synergistic effect and favorable clinical outcome. We conclude that the combined therapy of HFOV and continuous inhaled iPGI2 may be considered in RSV-associated hypoxemic respiratory failure in pediatric patients.

AB - In a 29-day-old premature infant with respiratory syncytial virus (RSV) pneumonia, we have shown an additive effect of high-frequency oscillatory ventilation (HFOV) and continuous inhalation of prostacyclin (iPGI2) with improvement of ventilation and oxygenation. The addition of continuous inhaled iPGI2 to HFOV was beneficial in the treatment of hypoxemic respiratory failure owing to RSV-associated pneumonia. The improvement in alveolar recruitment by increasing lung expansion by HFOV along with less ventilation-perfusion mismatch by iPGI2 appears to be responsible for the synergistic effect and favorable clinical outcome. We conclude that the combined therapy of HFOV and continuous inhaled iPGI2 may be considered in RSV-associated hypoxemic respiratory failure in pediatric patients.

KW - Premature infant

KW - Prostacyclin inhalation

KW - Respiratory failure

KW - Respiratory syncytial virus

UR - http://www.scopus.com/inward/record.url?scp=84864498858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864498858&partnerID=8YFLogxK

U2 - 10.1542/peds.2011-0239

DO - 10.1542/peds.2011-0239

M3 - Article

C2 - 22753555

AN - SCOPUS:84864498858

VL - 130

SP - e442-e445

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -